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Antibiotic resistance has become one of the most challenging problems in health care.
Bacteria conjugation is one of the main mechanisms whereby bacteria become resistant
to antibiotics. Therefore, the search for specific conjugation inhibitors (COINs) is of
interest in the fight against the spread of antibiotic resistances in a variety of laboratory
and natural environments. Several compounds, discovered as COINs, are promising
candidates in the fight against plasmid dissemination. In this review, we survey the
effectiveness and toxicity of the most relevant compounds. Particular emphasis has
been placed on unsaturated fatty acid derivatives, as they have been shown to be
efficient in preventing plasmid invasiveness in bacterial populations. Biochemical and
structural studies have provided insights concerning their potential molecular targets
and inhibitory mechanisms. These findings open a new avenue in the search of new
and more effective synthetic inhibitors. In this pursuit, the use of structure-based drug
design methods will be of great importance for the screening of ligands and binding
sites of putative targets.
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INTRODUCTION
Antibiotic resistance is becoming a major threat for human health (WHO, 2014). Widespread
abuse of antibiotics in human health and food production are threating our current health systems
and challenge future care (Giske et al., 2008; Boucher et al., 2009; Rice, 2009; Chang et al.,
2015). However, despite these threats, few new antibiotics are becoming available to fight against
multi-resistant bugs (Gould and Bal, 2013; Hede, 2014). Bacterial conjugation is one of the main
mechanisms whereby bacteria become resistant to antibiotics (Mazel and Davies, 1999; Waters,
1999). Thus, the search for specific conjugation inhibitors (COINs) is a foremost concern in the
fight against the spread of antibiotic resistance genes (Smith and Romesberg, 2007; Baquero et al.,
2011; Baym et al., 2016). In this pursuit, several compounds were reported to inhibit bacterial
conjugation specifically, although most turned out to be unspecific growth inhibitors (Michel-
Briand and Laporte, 1985; Hooper et al., 1989; Conter et al., 2002; Lujan et al., 2007; Nash et al.,
2012).
Bacterial conjugation is a mechanism by which DNA is transferred between two bacterial cells.
The process consists of two steps. In a first stage, DNA is mobilized by a set of proteins, encoded
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by MOB genes. In a second step, DNA is transported across a
secretion system [type IV secretion system (T4SS)] (de la Cruz
et al., 2010; Cabezón et al., 2015). T4SS is a complex formed
by proteins encoded by another set of genes, also known as
MPF (mating pore formation) genes (Fernandez-Lopez et al.,
2006). Conjugative Gram negative bacteria usually contain three
MOB genes encoding proteins involved in DNA processing
(Smillie et al., 2010). The most ubiquitous of these genes encodes
a relaxase protein, which cleaves one of the plasmid strands
at the origin of transfer (oriT) (Garcillán-Barcia et al., 2009)
(Supplementary Figure S1A). Upon this, the relaxase protein
remains covalently bound to the DNA at the 5′ end. This
nucleoprotein complex is recruited at the secretion channel
(T4SS) with the assistance of the coupling protein, an ATPase
present in most conjugative plasmids (Llosa et al., 2002; Tato
et al., 2005) (Supplementary Figure S1B). A third, accessory
protein is usually involved to ensure the correct DNA folding for
the relaxase action (Moncalian and de la Cruz, 2004).
Conjugative T4SS are large multi-subunit complexes involved
in substrate transport and pilus biogenesis. The simplest
T4SS consists of 11 proteins, named VirB1 to VirB11, after
Agrobaterium tumefaciens T4SS (Christie et al., 2005, 2014).
This macromolecular complex spans across the inner and outer
membranes and the periplasm in between. T4SS architecture is
well-preserved in most conjugative bacteria, consisting of four
distinct sections: the pilus, the core channel complex, the inner
membrane platform and the hexameric ATPases that provide
the energy for substrate transport and pilus biogenesis (Cabezón
et al., 2015). One of them, the traffic ATPase VirB11, was shown
to be the target for inhibition by unsaturated fatty acids (Ripoll-
Rozada et al., 2016). Here, we will analyze the progress on the
different strategies to inhibit the VirB11 ATPase and the rest of
the T4SS machinery. The impact of these results on the fight
against the spread of antibiotic resistance genes is discussed.
Strategies for the Identification of
Conjugation Inhibitors
Bacterial conjugation has been reported to be inhibited
by a variety of compounds. Indeed, chemicals such as
heterocyclic compounds, intercalators, acridine dyes, or
quinolones were reported to inhibit conjugation (Hahn and
Ciak, 1976; Michel-Briand and Laporte, 1985; Molnar et al.,
1992; Mazel and Davies, 1999; Nash et al., 2012). However,
posterior revisions showed that these molecules were unspecific,
mainly affecting bacterial growth or DNA synthesis. Plants
are a rich source of bioactive compounds, such as phenolics,
which are able to modify bacterial resistances (Oyedemi et al.,
2016). Therefore, a current approach consists of isolating
molecules from different parts of medicinal plants to discover
new inhibitors. By using this approach, two new drugs:
rottlerin [5,7-dihydroxy-2,2-dimethyl-6-(2,4,6-trihydroxy-
3-methyl-5-acetylbenzyl)-8-cinnamoyl-1,2-chromene] and
the red compound (8-cinnamoyl-5,7-dihydroxy-2,2,6-
trimethylchromene) were identified as potent antibacterial
chemicals against Gram-positive bacteria. These compounds
did not hamper Gram-negative bacteria growth but inhibited
conjugal transfer of plasmids pKM101, TP114, pUB307, and R6K
(Oyedemi et al., 2016). The planar structure of the compounds
suggests that the target of these inhibitors might be the DNA
replication system but further studies are required to elucidate
the mode of inhibition of these agents.
Alternative attempts to inhibit bacterial conjugation have been
based on bottom up strategies, targeting essential compounds
of the secretion machinery. One study focused on targeting
the conjugative relaxase protein, which is the protein that
initiates conjugation upon nicking plasmid DNA at the origin
of transfer. Due to its key role in plasmid conjugation,
relaxases have been considered as potential targets for inhibitors.
Some of these potential relaxase-specific inhibitors belong to
the bisphosphonates family of compounds, such as etidronate
(Didronel) and clodronate (Bonefos) (Lujan et al., 2007).
These compounds were reported to be efficient in restraining
conjugative DNA transfer. However, these results turned out
to be misleading, as these putative inhibitors were found
to work as unspecific chelating agents (Nash et al., 2012).
An alternative method to inhibit specifically the conjugative
relaxase consisted of the expression of specific single chain Fv
antibodies (intrabodies) against the relaxase TrwC of conjugative
plasmid R388 (Garcillan-Barcia et al., 2007). Expression of these
intrabodies in the recipient cell prevented the accretion of the
conjugative plasmid. However, the usefulness of intrabodies in
practical clinical care is hampered by the need of a transgenic
recipient population expressing them. Besides, each intrabody
would be specific only against its cognate plasmid.
VirB8 is an essential assembly protein of bacterial T4SS that
also acts as molecular target of small-molecule inhibitors (Smith
et al., 2012). A high throughput assay based on the restoration
of interactions between two split domains of the Brucella VirB8
protein allowed the identification of several compounds that
inhibited protein-protein interactions (Paschos et al., 2011). One
of the most efficient molecules, B8I-2, is a salicylidene acyl-
hydrazide derivative, also known to inhibit T3SS (Keyser et al.,
2008). Posterior analysis by X-ray crystallography and in silico
docking of several of these compounds allowed the determination
of VirB8 binding site (Smith et al., 2012). Recently, it has
been reported that these small molecules also bind TraE, the
VirB8 homolog of the conjugative plasmid pKM101, and some
of them inhibit plasmid transfer (Casu et al., 2016). Although
some of these molecules displayed a low Kd value in in vitro
binding experiments, no significant impact was observed on
plasmid transfer frequencies, with a 10-fold reduction as the
strongest effect. Moreover, none of these molecules had an effect
on the conjugation of the unrelated plasmid RP4, diminishing
the effectiveness of these compounds to overcome antibiotic
resistance.
Other alternatives to develop specific inhibitors focused on
the conjugative pilus. These appendages are targeted by a
variety of bacteriophages that, upon binding to them, enter
inside the bacteria cytoplasm. Some of these bacteriophages are
specific to conjugative pili and, therefore, have the potential of
discriminating between different bacterial species. For instance,
filamentous bacteriophages, such as M13, display high affinity
for F-type pilus. This interaction is mediated by the phage
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FIGURE 1 | High-throughput conjugation (HTC) assay. A whole-cell automated assay for conjugation based on fluorescence emission of transconjugant cells.
A fluorescent protein (GFP) is cloned in the conjugative plasmid (CP) under the control of pT7 promoter and transformed in donor cells. Recipient cells contains a T7
RNA polymerase gene cloned in the bacteria chromosome. Upon mating, the conjugative plasmid is transferred into the recipient cell. The resultant transconjugants
will express the GFP after addition of IPTG (isopropyl-β-D-thiogalactopyranoside). Upon induction, the emission fluorescence of GFP is measured, along with the
optical densities (ODs) of the cultures. Conjugation frequencies are estimated as a ratio between the fluorescence emitted by transconjugant cells and the total
number of cells measured by the OD (for further details on this method, please see Getino et al., 2015).
coat protein g3p. Addition of the soluble N-terminal domain
of g3p to F-plasmid containing bacteria resulted in inhibition
of conjugation (Lin et al., 2011). Considering that conjugative
pili are needed for bacterial cell contact (Anthony et al., 1994),
a step required for the spread of antibiotic resistance genes,
the use of specific compounds that inhibit pilus formation
could result in a powerful strategy to fight against this
problem.
In that sense, peptidomimetic small molecules, such as
C10 and KSK85, have been found to disrupt T4SS-dependent
transport of pathogenic factors, as well as DNA transfer in
conjugative Escherichia coli. KSK85 acts impeding biogenesis of
the pilus appendage, whereas C10 disrupts T4SS activity without
affecting pilus assembly (Shaffer et al., 2016). In this case, authors
have used a phenotypic screen to identify these two inhibitors.
Both compounds have been tested in plasmids pKM101 (IncN)
and R1-16 (IncF) but conjugation efficiency is only decreased to
25% and a high concentration of inhibitor is required (150 µM).
Therefore, although these compounds are promising scaffolds,
new derivatives need to be found to inhibit more effectively the
conjugative process.
A novel approach in the pursuit of specific COINs is
the screening of potential compounds in whole-cell assays
(Figure 1). This methodology should be designed in a way that
discriminates COINs from false positives affecting cell growth.
Thus, the development of luminescence-based high-throughput
conjugation (HTC) assays has been shown to be effective in the
identification of potential hits. By using HTC assays, unsaturated
fatty acids were found to inhibit conjugation of IncF and IncW
plasmids without affecting cell growth (Fernández-Lopez et al.,
2005). To this end, a library consisting of more than 12,000
natural compounds (NatChem library) was tested. The most
effective COIN found in this screening was dehydrocrepnynic
acid (DHCA) (Fernández-Lopez et al., 2005). Considering that
this compound was extracted from tropical plant seeds (Gussoni
et al., 1994) the viability of using it without vast downstream
process improvement is limited.
Nonetheless, by using DHCA structure as a chemical template,
new synthetic compounds were developed as specific COINs.
In particular, synthetic 2-hexadecynoic acid (2-HDA) and other
2-alkynoic fatty acids (2-AFAs) were found to be specific
inhibitors of a wide range of conjugative plasmids in different
bacteria, including the highly infective and prevalent IncF
plasmids (Getino et al., 2015). Furthermore, due to the effect of
plasmid burden on host fitness, 2-AFAs could in fact eliminate
transmissible plasmids, such as IncF, from bacterial populations.
However, other plasmid groups, such as IncN and IncP, were not
affected (Fernández-Lopez et al., 2005; Getino et al., 2015).
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FIGURE 2 | Blind docking of fatty acids in TrwD. Docking predictions between a molecular model of TrwD, the traffic ATPase of the conjugative plasmid R388, and
linoleic acid and 2-HDA are shown (A,B) (Ripoll-Rozada et al., 2016). These unsaturated fatty acids bind to a pocket formed by the end of the N-terminal domain
(NTD, wheat) and the linker region (green) that connects it to the C-terminal domain (CTD, purple). An electrostatic map showing these interactions is included in (C).
Inhibitor binding sites in the hexameric TrwD protein are shown in (D,E), corresponding to side and top views, respectively. Docking was performed using the
EADock dihedral spacing sampling engine of the Swiss-dock server (Grosdidier et al., 2011).
In addition to 2-AFAs compounds, another family of bioactive
compounds was tested in the search for COINs. This collection,
named AQUAc, contains more than 1,600 natural compounds.
AQUAc was evaluated in order to find potential COINs (Getino
et al., 2016). As a result, new COINs were found. Among them,
tanzawaic acids A and B were identified as best hits. They
specifically inhibited IncW and IncFII conjugative plasmids. The
advantage of these compounds is their lower toxicity to animal
cells, in comparison to other synthetic COINs. Unsaturated fatty
acids (oleic and linoleic acids), 2-HDA, 2-alkynoic fatty acids
and tanzawaic acids, all share similar chemical characteristics:
a carboxylic group, a long unsaturated carbon chain and the
presence of double or triple bonds. These compounds present a
100-fold reduction in plasmid transfer frequencies and, although
higher inhibition rates must be achieved to maximize their
effectiveness, they constitute key scaffold structures on which
to develop more potent and specific COINs. In that respect,
knowing the molecular target of these compounds is extremely
important, since the use of structure-based drug design (SBDD)
methods will allow the design of modified synthetic compounds
with higher binding affinities.
Unsaturated Fatty Acids As Specific
Inhibitors of Conjugative Traffic ATPases
Bacterial conjugation is driven by a group of ATPases that
empowers almost every step in the conjugative process:
DNA unwinding, DNA transport, pilus biogenesis and protein
transport (Cabezón et al., 2015). Each of these steps is catalyzed
by a specific ATPase, that in the conjugative plasmid R388 are
named TrwC, TrwB, TrwK, and TrwD, respectively. TrwC is a
protein that nicks the DNA, thus relaxing the conjugative plasmid
in an ATP-independent manner (Llosa et al., 1995, 1996). In
addition, TrwC displays a DNA helicase activity that results in
nucleic acid unwinding (Grandoso et al., 1994; Llosa et al., 1996).
TrwB is a DNA-dependent ATPase involved in DNA transfer to
the secretion channel (Tato et al., 2005, 2007; Matilla et al., 2010).
TrwK is a hexameric ATPase (Arechaga et al., 2008; Peña et al.,
2011) that participates in the transport of the pilin molecules
from the inner to the outer membranes during pilus biogenesis
(Kerr and Christie, 2010). Finally, TrwD is a traffic ATPase
that contributes to pilus biogenesis and to DNA translocation
(Atmakuri et al., 2004), thus working as a molecular switch
between pilus synthesis and substrate transport (Ripoll-Rozada
et al., 2013).
Each of these ATPases has been purified to homogeneity and
their enzymatic activities have been characterized (Grandoso
et al., 1994; Tato et al., 2005; Arechaga et al., 2008; Ripoll-Rozada
et al., 2012). The kinetic parameters of each ATPase were analyzed
in the presence of the unsaturated fatty acids shown to be efficient
COINs (Ripoll-Rozada et al., 2016). Interestingly, only the traffic
ATPase TrwD was inhibited by unsaturated fatty acids, such a
linoleic acid, and 2-AFAs like 2-HDA. The kinetic parameters for
TrwD ATPase inhibition by these fatty acids were determined,
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indicating that in all cases it was a non-competitive inhibition
(Ripoll-Rozada et al., 2016). In contrast, saturated fatty acids,
such as palmitic acid, showed no inhibitory effect in conjugation
experiments and in ATPase assays.
TrwD belongs to the secretion ATPase superfamily, which also
includes members of Type II secretion, Type IV pilus and flagellar
biogenesis machineries (Planet et al., 2001). All members of this
superfamily are hexameric ATPases, in which each monomer is
formed by two domains at the N- and C-termini (NTD and
CTD, respectively), connected by a flexible linker of a variable
length (Planet et al., 2001; Peña and Arechaga, 2013). ATPase
catalysis is driven by swapping this linker over the NTD and CTD
(Savvides et al., 2003; Hare et al., 2006). Blind docking predictions
(Grosdidier et al., 2011) suggested a putative binding site for uFAs
and 2-aFAs located at the end of the NTD and beginning of the
linker region that connects it to the CTD where the nucleotide
binding site is located (Figure 2) (Ripoll-Rozada et al., 2016).
These predictions were compatible with a model in which the
mode of action of the inhibitors consisted in preventing the
swapping movements between the N- and C-terminal domains
along the linker region that are required in the catalytic cycle of
the protein.
In summary, the discovery of traffic ATPases as potential
targets of bacterial COINs opens a promising avenue for the
development of new and more potent compounds capable to
impair the dissemination of antibiotic resistance genes. However,
despite these promising data, the efficacy of these inhibitors to
prevent the general spread of antibiotic resistance in naturally
occurring environments (Martinez, 2008; von Wintersdorff et al.,
2016), hospitals, wastewater systems (Hocquet et al., 2016),
agriculture (Capita and Alonso-Calleja, 2013; Economou and
Gousia, 2015) and farming settings (Wegener, 2003) needs
to be tested. Even today, the main reservoirs where the
antibiotic resistance genes arise from and how these genes
are rapidly acquired by human pathogens are a matter of
debate. COINs could be effective in the discovery of these
natural reservoirs. Experiments in controlled microcosms (e.g.,
freshwater microcosms) and/or experimental animals (e.g.,
mice gut) should be most instructive. Not only COIN-related
experiments will help to identify reservoirs, they will also serve
to quantify the dynamics of plasmids in those experiments and
the rate at which they can be mobilized to recipient strains that
are potential human pathogens. These are some of the exciting
goals of ongoing COINs research.
OUTLOOK
The battle against antibiotic resistance is a challenging problem
which is likely to become a progressively increasing burden to
our health systems. Several approaches are currently envisaged
to fight back against antibiotic resistant bugs. Among them,
a promising alternative consists of preventing the propagation
of antibiotic resistance genes. Bacterial conjugation is the main
mechanism for the wide spread dissemination of these genes.
Hence, the search of compounds able to specifically inhibit
bacterial conjugation is a preeminent undertaking in the global
war against antibiotic resistant bugs. Here, we have reviewed
several compounds that are competent in this pursuit. Among
these, unsaturated fatty acids and derivatives have been proved to
be the most efficient specific COINs. Moreover, the identification
of the traffic ATPase TrwD as the molecular target of these
uFAs enables the future development of more efficient inhibitors
directed against this essential protein of T4SS.
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